Allakos Inc (ALLK)
1.12
+0.07
(+6.67%)
USD |
NASDAQ |
May 01, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Allakos Research and Development Expense (Quarterly): 53.80M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.80M |
| September 30, 2023 | 36.75M |
| June 30, 2023 | 27.28M |
| March 31, 2023 | 33.08M |
| December 31, 2022 | 35.39M |
| September 30, 2022 | 18.44M |
| June 30, 2022 | 34.45M |
| March 31, 2022 | 176.81M |
| December 31, 2021 | 72.87M |
| September 30, 2021 | 43.56M |
| June 30, 2021 | 40.98M |
| March 31, 2021 | 38.92M |
| December 31, 2020 | 28.52M |
| September 30, 2020 | 30.38M |
| Date | Value |
|---|---|
| June 30, 2020 | 28.35M |
| March 31, 2020 | 18.28M |
| December 31, 2019 | 16.58M |
| September 30, 2019 | 16.07M |
| June 30, 2019 | 14.11M |
| March 31, 2019 | 15.10M |
| December 31, 2018 | 11.03M |
| September 30, 2018 | 8.706M |
| June 30, 2018 | 7.149M |
| March 31, 2018 | 6.401M |
| December 31, 2017 | 5.051M |
| September 30, 2017 | 5.333M |
| June 30, 2017 | 3.758M |
| March 31, 2017 | 4.364M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
14.11M
Minimum
Jun 2019
176.81M
Maximum
Mar 2022
40.24M
Average
33.08M
Median
Mar 2023
Research and Development Expense (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 17.12M |
| RAPT Therapeutics Inc | 26.76M |
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 5.554M |
| iBio Inc | 1.535M |